AYR Wellness Announces Leadership Update
Rhea-AI Summary
AYR Wellness (OTCQX: AYRWF) announced that interim Chief Financial Officer Donna Granato will depart effective December 31, 2025. The company said the departure occurs as AYR continues an orderly wind down of its existing corporate entity while transitioning go‑forward assets to a new AYR.
Company leaders credited Granato with leadership during the initial phases of the business's debt restructuring and ownership transition, and thanked her for contributions during a period described as complex and uncertain.
Positive
- Interim CFO helped advance initial phases of debt restructuring
- Company is executing an orderly wind down of the existing entity
Negative
- Interim CFO departure effective December 31, 2025
- Leadership change occurs amid ownership transition and restructuring
News Market Reaction
On the day this news was published, AYRWF declined 9.09%, reflecting a notable negative market reaction.
Data tracked by StockTitan Argus on the day of publication.
MIAMI, Dec. 30, 2025 (GLOBE NEWSWIRE) -- AYR Wellness Inc. (CSE: AYR.A, OTCQX: AYRWF) (“AYR” or the “Company”), a leading vertically integrated U.S. multi-state cannabis operator, announces that Donna Granato, the Company’s interim Chief Financial Officer (“CFO”), will depart AYR December 31, 2025.
AYR Interim CEO Blake Holzgrafe said, “As we continue the orderly wind down of AYR’s existing corporate entity and transition the Company’s go-forward assets to the new AYR, we thank Donna for her contributions to the Company.”
Scott Davido, former interim CEO of AYR said, “Donna stepped in during a period of significant complexity and uncertainty for the Company. Her leadership, judgment, and commitment were instrumental in helping guide the business through the initial, critical phases of our debt restructuring and ownership transition. We are thankful for her steady hands and partnership throughout this restructuring process.”
Forward-Looking Statements
Certain statements contained in this news release may contain forward-looking information or may be forward-looking statements (collectively, "forward-looking statements") within the meaning of applicable securities laws. Forward-looking statements are often, but not always, identified by the use of words such as "target", "expect", "anticipate", "believe", "foresee", "could", "would", "estimate", "goal", "outlook", "intend", "plan", "seek", "will", "may", "tracking", "pacing" and "should" and similar expressions or words suggesting future outcomes. This news release includes forward-looking statements pertaining to, among other things, the wind down and transition of the business currently conducted by AYR. Numerous risks and uncertainties could cause actual events and results to differ materially from the estimates, beliefs and assumptions expressed or implied in the forward-looking statements. Forward-looking statements involve known and unknown risks and uncertainties that may cause actual results to differ materially from those anticipated. These risks and uncertainties include, among others, those described in the Company’s public filings, the ability to satisfy conditions and milestones under the restructuring support agreement, market and regulatory factors, and other risks inherent in the cannabis industry. AYR has no intention, and undertakes no obligation, to update or revise any forward-looking statements, whether as a result of new information, future events, or otherwise, except as required by law.
About AYR Wellness Inc.
AYR Wellness is a vertically integrated U.S. multi-state cannabis operator with over 90 licensed retail locations across Florida, Pennsylvania, New Jersey, Ohio, Nevada, and Virginia. The Company cultivates, manufactures, and retails a broad portfolio of high-quality cannabis products, supporting both medical patients and adult-use consumers. AYR also offers a growing suite of CPG brands—including Kynd, Haze, and Later Days—designed to meet a wide range of consumer needs across its markets.
For more information, please visit www.ayrwellness.com.
Company/Media Contact:
Robert Vanisko
SVP, Public Affairs
T: (786) 885-0397
Email: comms@ayrwellness.com
Investor Relations Contact:
Sean Mansouri, CFA
Elevate IR
T: (786) 885-0397